Search by Drug Name or NDC
NDC 00781-4075-15 Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium Details
Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium
Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is .
MedlinePlus Drug Summary
Oral contraceptives (birth-control pills) are used to prevent pregnancy. Estrogen and progestin are two female sex hormones. Combinations of estrogen and progestin work by preventing ovulation (the release of eggs from the ovaries). They also change the lining of the uterus (womb) to prevent pregnancy from developing and change the mucus at the cervix (opening of the uterus) to prevent sperm (male reproductive cells) from entering. Oral contraceptives are a very effective method of birth control, but they do not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases. Some brands of oral contraceptives are also used to treat acne in certain patients. Oral contraceptives treat acne by decreasing the amounts of certain natural substances that can cause acne. Some oral contraceptives (Beyaz, Yaz) are also used to relieve the symptoms of premenstrual dysphoric disorder (physical and emotional symptoms that occur before the menstrual period each month) in women who have chosen to use an oral contraceptive to prevent pregnancy.
Related Packages: 00781-4075-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Estrogen and Progestin (Oral Contraceptives)
Product Information
NDC | 00781-4075 |
---|---|
Product ID | 0781-4075_e0847494-9c83-446b-b999-706bcbf9c8d3 |
Associated GPIs | 25990003200320 |
GCN Sequence Number | 066726 |
GCN Sequence Number Description | drospir/eth estra/levomefol Ca TABLET 3-0.02(24) ORAL |
HIC3 | G8A |
HIC3 Description | CONTRACEPTIVES,ORAL |
GCN | 29095 |
HICL Sequence Number | 037200 |
HICL Sequence Number Description | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM |
Brand/Generic | Generic |
Proprietary Name | Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Sandoz Inc |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA AUTHORIZED GENERIC |
Application Number | NDA022532 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00781-4075-15 (00781407515)
NDC Package Code | 0781-4075-15 |
---|---|
Billing NDC | 00781407515 |
Package | 3 BLISTER PACK in 1 CARTON (0781-4075-15) / 1 KIT in 1 BLISTER PACK (0781-4075-52) |
Marketing Start Date | 2016-10-12 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 2.98153 |
Pricing Unit | EA |
Effective Date | 2024-01-17 |
NDC Description | DROSP-EE-LEVOMEF 3-0.02-0.451 |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 6 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |